These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 15093603)
1. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Charnay C; Bégu S; Tourné-Péteilh C; Nicole L; Lerner DA; Devoisselle JM Eur J Pharm Biopharm; 2004 May; 57(3):533-40. PubMed ID: 15093603 [TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica material TUD-1 as a drug delivery system. Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183 [TBL] [Abstract][Full Text] [Related]
3. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen. Mellaerts R; Jammaer JA; Van Speybroeck M; Chen H; Van Humbeeck J; Augustijns P; Van den Mooter G; Martens JA Langmuir; 2008 Aug; 24(16):8651-9. PubMed ID: 18630936 [TBL] [Abstract][Full Text] [Related]
4. Potential of amorphous microporous silica for ibuprofen controlled release. Aerts CA; Verraedt E; Depla A; Follens L; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G; Mellaerts R; Martens JA Int J Pharm; 2010 Sep; 397(1-2):84-91. PubMed ID: 20619331 [TBL] [Abstract][Full Text] [Related]
5. Studies on a new carrier of trimethylsilyl-modified mesoporous material for controlled drug delivery. Tang Q; Xu Y; Wu D; Sun Y; Wang J; Xu J; Deng F J Control Release; 2006 Aug; 114(1):41-6. PubMed ID: 16784793 [TBL] [Abstract][Full Text] [Related]
6. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen. Yang YJ; Tao X; Hou Q; Chen JF Acta Biomater; 2009 Nov; 5(9):3488-96. PubMed ID: 19442764 [TBL] [Abstract][Full Text] [Related]
7. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique. Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738 [TBL] [Abstract][Full Text] [Related]
8. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system. Yang P; Huang S; Kong D; Lin J; Fu H Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013 [TBL] [Abstract][Full Text] [Related]
9. Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems. Yang P; Quan Z; Lu L; Huang S; Lin J Biomaterials; 2008 Feb; 29(6):692-702. PubMed ID: 17996294 [TBL] [Abstract][Full Text] [Related]
11. Polymer-mesoporous silica materials templated with an oppositely charged surfactant/polymer system for drug delivery. Lin H; Zhu G; Xing J; Gao B; Qiu S Langmuir; 2009 Sep; 25(17):10159-64. PubMed ID: 19552374 [TBL] [Abstract][Full Text] [Related]
12. Gas adsorption in mesoporous micelle-templated silicas: MCM-41, MCM-48, and SBA-15. Coasne B; Galarneau A; Di Renzo F; Pellenq RJ Langmuir; 2006 Dec; 22(26):11097-105. PubMed ID: 17154590 [TBL] [Abstract][Full Text] [Related]
13. A magnetic, luminescent and mesoporous core-shell structured composite material as drug carrier. Yang P; Quan Z; Hou Z; Li C; Kang X; Cheng Z; Lin J Biomaterials; 2009 Sep; 30(27):4786-95. PubMed ID: 19520428 [TBL] [Abstract][Full Text] [Related]
14. Effective controlled release of captopril by silylation of mesoporous MCM-41. Qu F; Zhu G; Huang S; Li S; Qiu S Chemphyschem; 2006 Feb; 7(2):400-6. PubMed ID: 16411260 [TBL] [Abstract][Full Text] [Related]
15. Ibuprofen loading in surfactant-templated silica: role of the solvent according to the polarizable continuum model. Fernández-Núñez M; Zorrilla D; Montes A; Mosquera MJ J Phys Chem A; 2009 Oct; 113(42):11367-75. PubMed ID: 19780578 [TBL] [Abstract][Full Text] [Related]
16. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate. Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966 [TBL] [Abstract][Full Text] [Related]
18. Variation of the crystal growth of mesoporous silica nanoparticles and the evaluation to ibuprofen loading and release. Kamarudin NH; Jalil AA; Triwahyono S; Artika V; Salleh NF; Karim AH; Jaafar NF; Sazegar MR; Mukti RR; Hameed BH; Johari A J Colloid Interface Sci; 2014 May; 421():6-13. PubMed ID: 24594025 [TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of glycidyl methacrylate organo bridges grafted mesoporous silica SBA-15 as ibuprofen and mesalamine carrier for controlled release. Rehman F; Rahim A; Airoldi C; Volpe PLO Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():970-979. PubMed ID: 26652455 [TBL] [Abstract][Full Text] [Related]
20. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour. Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]